Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence

European Journal of Medical Research

Volumn 16, Issue 3, 2011, Pages 101-107

  Vogel, M ^a   Friedrich, O ^a   Luchters G ^b   Holleczek, B ^c   Wasmuth, J C ^a   Anadol, E ^a   Schwarze Zander, C ^a   Nattermann, J ^a   Oldenburg, J ^a   Sauerbruch, T ^a   Rockstroh, J K ^a   Spengler, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c SAARLAND CANCER REGISTRY   (Germany)

Author keywords

Carcinoma; CD4 T cells; HAART; HIV; Lymphoma

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANUS CANCER; ARTICLE; BLOOD; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; COLORECTAL CANCER; DISEASE TRANSMISSION; ENDOMETRIUM CANCER; ETHNICITY; FEMALE; HEPATITIS B; HEPATITIS C; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIXED INFECTION; NONHODGKIN LYMPHOMA; ONCOGENIC INFECTION; OROPHARYNX CANCER; POISSON DISTRIBUTION; RISK ASSESSMENT; RISK REDUCTION; THYROID CANCER; UTERINE CERVIX CARCINOMA; ANUS CARCINOMA; COHORT ANALYSIS; CONTROLLED STUDY; GERMANY; HIGH RISK POPULATION; IMMUNOCOMPETENCE; LIVER CELL CARCINOMA; PREDICTION; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; TUMOR INVASION;

EID: 79954457002     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-3-101     Document Type: Article

References (22)

1. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003; 362:22-9. (Pubitemid 36835816)
2. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003; 349:1993-2003.
3. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007; 45:1593-601.
4. Rosenthal E, Pialoux G, Bernard N, et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat. 2007;14:183-8.
5. Castro K, Ward J, Slutsker L, Buehler J, Jaffe H and Berkelman R. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults. Morbidity and Mortality Weekly Report. 1992; 41:1.
6. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006; 20:1645-54.
7. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148:728-36.
8. Shiels MS, Cole SR, Kirk GD and Poole C. A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-infected Individuals. J Acquir Immune Defic Syndr. 2009.
9. Katalinic A, Bertz J, Haberland J and Wolf U. Cancer in Germany 2003-2004. Incidence and Trends. Berlin: Association of Population-based Cancer Registries in Germany and Robert Koch Institute; 2008.
10. Haberland J, Bertz J, Gorsch B and Schon D. [Cancer incidence estimates for Germany via log-linear models]. Gesundheitswesen. 2001; 63:556-60.
11. Boyle P and Parkin D. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ. 1991; 95:126-58.
12. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2009.
13. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E and Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009.
14. Albrecht H, Helm EB, Plettenberg A, et al. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature. Genitourin Med. 1994; 70:394-8.
15. Laney AS, Cannon MJ, Jaffe HW, et al. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. AIDS. 2007;21:1541-5. (Pubitemid 47075474)
16. Grulich AE, van Leeuwen MT, Falster MO and Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370:59-67. (Pubitemid 47017468)
17. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009; 27:884-90.
18. Bruyand M, Thiebaut R, Lawson-Ayayi S, et al. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis. 2009; 49:1109-16.
19. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97:425-32. (Pubitemid 40528605)
20. Clumeck N, Pozniak A, Raffi F and EACS Executive Committee. Guidelines on the Clinical Management and Treatment of HIV Infected Adults in Europe. EACS European AIDS Clinical Society. Paris, France: available online at www.europeanaidsclinicalsociety.org/guidelines.asp, accessed December 8th, 2009.
21. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services.December 1, 2009; 1-161. Available at www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf, accessed December 8th,.
22. Lackner AA, Mohan M and Veazey RS. The gastrointestinal tract and AIDS pathogenesis. Gastroenterology. 2009; 136:1965-78.